Folgen
Keine Story von Chr. Olesen Synthesis mehr verpassen.

Chr. Olesen Synthesis

Filtern
  • 08.10.2015 – 08:01

    Chr. Olesen Synthesis A/S Completes Financing

    Copenhagen, Denmark (ots/PRNewswire) - Chr. Olesen Synthesis A/S, the privately held Danish manufacturer of active pharmaceutical ingredients (APIs), announced it has raised EUR10 million through the sale of Series A Preferred Stock to the American private equity firm, Signet Healthcare Partners.  Chr. Olesen Synthesis, founded in the 1970's, was taken over in 2012 in a financial restructuring led by Chr. Olesen Group, a ...